Arax Advisory Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Arax Advisory Partners's KNSA Position: Q3 2026 in Review
Arax Advisory Partners increased its Kiniksa Pharmaceuticals (KNSA) stake by 15% in Q3 2026, buying an estimated $37.2K and bringing the position to 3,957 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.
Arax Advisory Partners first reported a position in KNSA in Q2 2024 and has held it in 8 quarters since. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Arax Advisory Partners held 3,957 shares of Kiniksa Pharmaceuticals worth $295K as of Q3 2026.
- Arax Advisory Partners bought 506 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $37.2K.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2080 holding.
- Arax Advisory Partners first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.